Latest Breaking News On - Bijan almassian - Page 1 : comparemela.com
Wayne State Study Advances Long-Term Ovarian Cancer Protection
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Study reports progress in long-term protection against ovarian cancer tumors
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
Immunotherapies. Vaccines. We’ve all had a crash course in these subjects during this year of the pandemic.
Now a Farmington startup is taking immunotherapies and vaccines in new directions in the battle against disease including COVID-19.
Bijan Almassian is president and CEO at CaroGen Corp. His small team five full-time employees and five part-timers occupies space in UConn Health’s Cell and Genome Building on Farmington Avenue. But much of the firm’s research is going on in laboratories spread across several universities.
CaroGen’s lead product is an immunotherapy that targets Hepatitis B, a viral disease that affects the liver and is spread through bodily fluids. While there are Hep B vaccines on the market, the one CaroGen is working on is for treating chronic Hepatitis B, a disease that afflicts 240 million people worldwide.